Advertisement

Topics

GlycoMimetics Appoints Scott Koenig of MacroGenics to Board of Directors

09:30 EDT 13 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Two Long-Time Board Members to Step Down After Company’s 2017 Annual Meeting GlycoMimetics, Inc. (NASDAQ: GLYC) announced today the appointment of Scott Koenig, M.D., Ph.D., to its Board of Directors. Dr. Koenig ...

Other Sources for this Article

GlycoMimetics, Inc.
Investor Contact:
Shari Annes
650-888-0902
sannes@annesassociates.com
or
Media Contact:
Jamie Lacey-Moreira
410-299-3310
jamielacey@presscommpr.com

NEXT ARTICLE

More From BioPortfolio on "GlycoMimetics Appoints Scott Koenig of MacroGenics to Board of Directors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...